Safe Proton Beam Re-irradiation With a Bioabsorbable Spacer in Pancreatic Cancer: A Case Report.
증례보고
2/5 보강
OpenAlex 토픽 ·
Radiation Therapy and Dosimetry
Advanced Radiotherapy Techniques
Radiopharmaceutical Chemistry and Applications
[PURPOSE] Proton beam therapy (PBT) re-irradiation for pancreatic cancer is challenging because of accumulated dose limits in surrounding gastrointestinal organs.
APA
Shintaro Shiba, Koichi Tokuuye, et al. (2026). Safe Proton Beam Re-irradiation With a Bioabsorbable Spacer in Pancreatic Cancer: A Case Report.. International journal of particle therapy, 20, 101311. https://doi.org/10.1016/j.ijpt.2026.101311
MLA
Shintaro Shiba, et al.. "Safe Proton Beam Re-irradiation With a Bioabsorbable Spacer in Pancreatic Cancer: A Case Report.." International journal of particle therapy, vol. 20, 2026, pp. 101311.
PMID
41952792 ↗
Abstract 한글 요약
[PURPOSE] Proton beam therapy (PBT) re-irradiation for pancreatic cancer is challenging because of accumulated dose limits in surrounding gastrointestinal organs. Bioabsorbable polyglycolic acid (PGA) spacers can reduce radiation exposure to adjacent organs. This report aims to detail the safe execution of PBT re-irradiation for recurrent pancreatic body cancer adjacent to the stomach using a PGA spacer and physically verify the spacer's proton beam blocking effectiveness via auto-activation positron emission tomography (AAPET).
[PATIENTS AND METHODS] A 77-year-old female with pancreatic body cancer experienced local residual disease 6 months after an initial PBT course (67.5 Gy (RBE)/25 fractions). To enable a second PBT, a 1-cm-thick PGA spacer was successfully placed between the stomach and the pancreas. The second PBT delivered 67.5 Gy (RBE) in 25 fractions using 2 posterior beams to avoid gastric passage. AAPET-CT was performed 3 times during the second PBT. Quantitative analysis compared the average Becquerel (Bq)/ml values in the planning target volume, the stomach (ventral to the spacer), and abdominal regions outside the field.
[RESULTS] Maximum doses to the stomach and duodenum were limited to 16.1 Gy (RBE) and 16.7 Gy (RBE), respectively. Quantitative AAPET analysis showed the average Bq/ml value in the planning target volume was significantly higher than in other regions. This visually and quantitatively confirmed the spacer's effectiveness in stopping the proton beams. Three months after the second PBT, the irradiated site was controlled, and no adverse events related to PBT or PGA spacers were observed.
[CONCLUSION] In a case of recurrent pancreatic body cancer adjacent to the stomach, safe proton beam re-irradiation was successfully performed by placing a PGA spacer. PGA spacer placement may represent an effective strategy for safely achieving PBT re-irradiation for recurrent pancreatic cancer near the gastrointestinal tract.
[PATIENTS AND METHODS] A 77-year-old female with pancreatic body cancer experienced local residual disease 6 months after an initial PBT course (67.5 Gy (RBE)/25 fractions). To enable a second PBT, a 1-cm-thick PGA spacer was successfully placed between the stomach and the pancreas. The second PBT delivered 67.5 Gy (RBE) in 25 fractions using 2 posterior beams to avoid gastric passage. AAPET-CT was performed 3 times during the second PBT. Quantitative analysis compared the average Becquerel (Bq)/ml values in the planning target volume, the stomach (ventral to the spacer), and abdominal regions outside the field.
[RESULTS] Maximum doses to the stomach and duodenum were limited to 16.1 Gy (RBE) and 16.7 Gy (RBE), respectively. Quantitative AAPET analysis showed the average Bq/ml value in the planning target volume was significantly higher than in other regions. This visually and quantitatively confirmed the spacer's effectiveness in stopping the proton beams. Three months after the second PBT, the irradiated site was controlled, and no adverse events related to PBT or PGA spacers were observed.
[CONCLUSION] In a case of recurrent pancreatic body cancer adjacent to the stomach, safe proton beam re-irradiation was successfully performed by placing a PGA spacer. PGA spacer placement may represent an effective strategy for safely achieving PBT re-irradiation for recurrent pancreatic cancer near the gastrointestinal tract.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (2)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Key Considerations for Targeting in Pancreatic Cancer: Potential Impact on the Treatment Paradigm.
- The role of disulfidptosis-driven tumor microenvironment remodeling in pancreatic cancer progression.
- Current Systemic Treatment Options for Advanced Pancreatic Cancer-An Overview Article.
- Editorial: Altered metabolic traits in gastro-intestinal tract cancers, volume II.
- Racial Disparities in Pancreatic Cancer: A Comprehensive Population-Based Analysis of Survival, Surgical Access, and Prognostic Factors.
- Impact of Skeletal Muscle-related Parameters on Survival in Patients with Advanced Pancreatic Cancer Treated with Gemcitabine plus Nab-paclitaxel as First-line Chemotherapy.